pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›SYNALGOS-DC
drug
save

SYNALGOS-DC

updated 5mo ago
by Sun Pharmaceutical Industries Ltd
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval354 co-mentions · 104 sources
  • drugBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE354 co-mentions · 107 sources
  • drugStem Cell Therapy for Coronavirus Disease 2019 (COVID-19)288 co-mentions · 107 sources
  • drugaspirin288 co-mentions · 107 sources
  • tagSmall Molecule177 co-mentions · 104 sources
  • drugcodeine94 co-mentions · 47 sources
  • drugPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE94 co-mentions · 47 sources
  • drugPROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE94 co-mentions · 47 sources

all catalysts(0)

nothing on the calendar yet

Trials studying SYNALGOS-DC

  • phase3Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosisactive not recruitingn=1,683
  • phase3Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapyterminatedn=3,021
  • phase1A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participantsrecruitingn=16
  • phase2Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapynot yet recruitingn=10
  • N/AThromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularizationactive not recruitingn=130
  • phase1Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjectscompletedn=40
  • N/AHighest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patientsrecruitingn=1,556
  • phase2Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgeryactive not recruitingn=12

News(4)

  • White House takes stock of US-based manufacturing for 86 essential drugs
    The White House's Office of Management and Budget (OMB) is asking for more information on the domestic production of 86 essential medicines, such as the pain reliever aspirin and the blood pressure…
    endpoints · 1d ago
  • Vaccines take center stage at federal autism advisory committee
    Comments about vaccines overshadowed an advisory committee meeting to discuss a plan for boosting federal funding for autism research.
    stat · 1mo ago
  • Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC Prevention
    Colton Jones, MD, shares data from a retrospective analysis of GLP-1 receptor agonists vs aspirin for the primary prevention of colorectal cancer.
    onclive · 4mo ago
  • Predicting consequences of new hepatitis B vaccine recs
    New data on public trust in science, AI and mental health, and other news from Morning Rounds
    stat · 5mo ago
brand
SYNALGOS-DC
generic
ASPIRIN
Data sources
ClinicalTrials.gov
last refreshed 3h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?